Toyota|$17.92 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$23.78 (¥3,753)-0.90%▼ (in JPY terms)
SoftBank|$39.98 (¥6,310)-5.83%▼ (in JPY terms)
MUFG|$22.45 (¥3,544)-1.17%▼ (in JPY terms)
Keyence|$508.58 (¥80,270)-1.15%▼ (in JPY terms)
Nintendo|$49.73 (¥7,849)-1.15%▼ (in JPY terms)
NTT|$1.08 (¥170)-0.23%▼ (in JPY terms)
Takeda|$35.75 (¥5,643)-1.54%▼ (in JPY terms)
Tokyo Electron|$76.66 (¥12,100)-3.82%▼ (in JPY terms)
Recruit|$105.71 (¥16,685)-0.42%▼ (in JPY terms)
ITOCHU|$13.78 (¥2,176)-1.23%▼ (in JPY terms)
Honda|$10.55 (¥1,665)-1.86%▼ (in JPY terms)
Shin-Etsu|$38.20 (¥6,030)+0.05%▲ (in JPY terms)
Tokio Marine|$3.21 (¥507)-2.61%▼ (in JPY terms)
Fast Retailing|$454.72 (¥71,770)-1.35%▼ (in JPY terms)
Toyota|$17.92 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$23.78 (¥3,753)-0.90%▼ (in JPY terms)
SoftBank|$39.98 (¥6,310)-5.83%▼ (in JPY terms)
MUFG|$22.45 (¥3,544)-1.17%▼ (in JPY terms)
Keyence|$508.58 (¥80,270)-1.15%▼ (in JPY terms)
Nintendo|$49.73 (¥7,849)-1.15%▼ (in JPY terms)
NTT|$1.08 (¥170)-0.23%▼ (in JPY terms)
Takeda|$35.75 (¥5,643)-1.54%▼ (in JPY terms)
Tokyo Electron|$76.66 (¥12,100)-3.82%▼ (in JPY terms)
Recruit|$105.71 (¥16,685)-0.42%▼ (in JPY terms)
ITOCHU|$13.78 (¥2,176)-1.23%▼ (in JPY terms)
Honda|$10.55 (¥1,665)-1.86%▼ (in JPY terms)
Shin-Etsu|$38.20 (¥6,030)+0.05%▲ (in JPY terms)
Tokio Marine|$3.21 (¥507)-2.61%▼ (in JPY terms)
Fast Retailing|$454.72 (¥71,770)-1.35%▼ (in JPY terms)

2026-09-30 TERUMO CORPORATION “Terumo has agreed to acquire Arsenal Medical, a US company specializing in cerebrovascular treatment technologies. By acquiring "NeoCast™," a liquid embolization material for chronic subdural hematoma currently under development, Terumo will expand its technology portfolio in the field of cerebrovascular treatment.”

2026-09-30 TERUMO CORPORATION “Terumo has agreed to acquire Arsenal Medical, a US company specializing in cerebrovascular treatment technologies. By acquiring "NeoCast™," a liquid embolization material for chronic subdural hematoma currently under development, Terumo will expand its technology portfolio in the field of cerebrovascular treatment.”

コメントする